Giridhara R Jayandharan

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Acute Myeloid Leukemia

High Fat Diet Induced

Top Venues

Journal of cellular and molecular medicine

Molecular pharmaceutics

Cancer gene therapy

Bioconjugate chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Pratiksha Sarangi, Mohankumar B Senthilkumar, Sonal Amit, Narendra Kumar, Giridhara R Jayandharan
AAV mediated repression of Neat1 lncRNA combined with F8 gene augmentation mitigates pathological mediators of joint disease in haemophilia. Journal of cellular and molecular medicine 28 (11) (2024)
Vijayata Singh, Subhajit Pathak, Narendra Kumar, Giridhara R Jayandharan
Development of an Optimized Promoter System for Exosomal and Naked AAV Vector-Based Suicide Gene Therapy in Hepatocellular Carcinoma. ACS omega 9 (28) (2024)
Vijayata Singh, Subhajit Pathak, Narendra Kumar, Giridhara R Jayandharan
Development of an Optimized Promoter System for Exosomal and Naked AAV Vector-Based Suicide Gene Therapy in Hepatocellular Carcinoma. ACS omega 9 (28) (2024)
Pratiksha Sarangi, Mohankumar B Senthilkumar, Sonal Amit, Narendra Kumar, Giridhara R Jayandharan
AAV mediated repression of Neat1 lncRNA combined with F8 gene augmentation mitigates pathological mediators of joint disease in haemophilia. Journal of cellular and molecular medicine 28 (11) (2024)
Pratiksha Sarangi, Mohankumar B Senthilkumar, Sonal Amit, Narendra Kumar, Giridhara R Jayandharan
AAV mediated repression of Neat1 lncRNA combined with F8 gene augmentation mitigates pathological mediators of joint disease in haemophilia. Journal of cellular and molecular medicine 28 (11) (2024)
Pratiksha Sarangi, Mohankumar B Senthilkumar, Narendra Kumar, Senthilnathan Senguttuvan, Madavan Vasudevan, Giridhara R Jayandharan
Potential role of long non-coding RNA H19 and Neat1 in haemophilic arthropathy. Journal of cellular and molecular medicine (2023)
Shubham Maurya, Pratiksha Sarangi, Giridhara R Jayandharan
Safety of Adeno-associated virus-based vector-mediated gene therapy-impact of vector dose. Cancer gene therapy 29 (10) (2022)
Pratheppa Rajagopal, Giridhara R Jayandharan, Uma Maheswari Krishnan
Evaluation of the Anticancer Activity of pH-Sensitive Polyketal Nanoparticles for Acute Myeloid Leukemia. Molecular pharmaceutics 18 (5) (2021)
Vijayata Singh, Nusrat Khan, Giridhara R Jayandharan
Vector engineering, strategies and targets in cancer gene therapy. Cancer gene therapy (2021)
Nusrat Khan, Sabna Cheemadan, Himanshi Saxena, Sridhar Bammidi, Giridhara R Jayandharan
MicroRNA-based recombinant AAV vector assembly improves efficiency of suicide gene transfer in a murine model of lymphoma. Cancer medicine 9 (9) (2020)
Shubham Maurya, Giridhara R Jayandharan
Gene Therapy: Contest between Adeno-Associated Virus and Host Cells and the Impact of UFMylation. Molecular pharmaceutics 17 (10) (2020)
Nusrat Israr Khan, Sridhar Bammidi, Sourav Chattopadhyay, Giridhara R Jayandharan
Combination Suicide Gene Delivery with an Adeno-Associated Virus Vector Encoding Inducible Caspase-9 and a Chemical Inducer of Dimerization Is Effective in a Xenotransplantation Model of Hepatocellular Carcinoma. Bioconjugate chemistry 30 (6) (2019)
Bertin Mary, Shubham Maurya, Mohit Kumar, Sridhar Bammidi, Vikas Kumar, Giridhara R Jayandharan
Molecular Engineering of Adeno-Associated Virus Capsid Improves Its Therapeutic Gene Transfer in Murine Models of Hemophilia and Retinal Degeneration. Molecular pharmaceutics 16 (11) (2019)
Nusrat Khan, Sridhar Bammidi, Giridhara R Jayandharan
A CD33 Antigen-Targeted AAV6 Vector Expressing an Inducible Caspase-9 Suicide Gene Is Therapeutic in a Xenotransplantation Model of Acute Myeloid Leukemia. Bioconjugate chemistry 30 (9) (2019)
Bertin Mary, Shubham Maurya, Sathyathithan Arumugam, Vikas Kumar, Giridhara R Jayandharan
Post-translational modifications in capsid proteins of recombinant adeno-associated virus (AAV) 1-rh10 serotypes. The FEBS journal 286 (24) (2019)